Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost-effectiveness of the Care Pathways - Effects of Patient Segmentation to Quality and Costs of Type 2 Diabetes and Substance Abuse Care and Services

NCT04619836 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT04619836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04619836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost-effectiveness of the Care Pathways - Effects of Patient Segmentation to Quality and Costs of Type 2 Diabetes and Substance Abuse Care and Services
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 26, 2020
Completion date
December 31, 2035
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, substance abuse